Author： Souza Elaine Cristina Lima de Ferreira Andrea Claudia Freitas Carvalho Denise Pires de
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.9, 2011-09, pp. : 1099-1112
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
The mTOR Pathway: A New Target in Cancer Therapy
Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. :
Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents
Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. :
mTOR inhibitors in the treatment of cancer
By Fasolo Angelica Sessa Cristiana
Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. :
mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. :